[go: up one dir, main page]

NO20070206L - Sammensetninger inneholdende strontium og vitamin D og anvendelser derav - Google Patents

Sammensetninger inneholdende strontium og vitamin D og anvendelser derav

Info

Publication number
NO20070206L
NO20070206L NO20070206A NO20070206A NO20070206L NO 20070206 L NO20070206 L NO 20070206L NO 20070206 A NO20070206 A NO 20070206A NO 20070206 A NO20070206 A NO 20070206A NO 20070206 L NO20070206 L NO 20070206L
Authority
NO
Norway
Prior art keywords
vitamin
strontium
compositions containing
containing strontium
pharmaceutical composition
Prior art date
Application number
NO20070206A
Other languages
English (en)
Inventor
John Nikolaj Hvarr Christensen
Original Assignee
Strontin Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34972075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070206(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Strontin Aps filed Critical Strontin Aps
Publication of NO20070206L publication Critical patent/NO20070206L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen angår funnet at meget gunstige farmakokinetiske egenskaper kan oppnås ved å kombinere to strontiumsalter i én farmasøytisk sammensetning. Den foreliggende oppfinnelsen angår i et aspekt en farmasøytisk sammensetning som omfatter minst to strontiumsalter for bruk som et medikament, da spesielt for behandling og forebygging av benlidelser så som osteoporose. Sammensetningen omfatter fortrinnsvis strontiumkarbonat og strontiumklorider. Videre kan sammensetningene inkludere en vitamin D-forbindelse, fortrinnsvis vitamin D3.
NO20070206A 2004-06-25 2007-01-11 Sammensetninger inneholdende strontium og vitamin D og anvendelser derav NO20070206L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400991 2004-06-25
DKPA200401733 2004-11-10
PCT/DK2005/000425 WO2006000224A2 (en) 2004-06-25 2005-06-24 Compositions comprising strontium and vitamin d and uses thereof

Publications (1)

Publication Number Publication Date
NO20070206L true NO20070206L (no) 2007-03-22

Family

ID=34972075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070206A NO20070206L (no) 2004-06-25 2007-01-11 Sammensetninger inneholdende strontium og vitamin D og anvendelser derav

Country Status (15)

Country Link
US (1) US8658206B2 (no)
EP (1) EP1768748B2 (no)
JP (2) JP5070046B2 (no)
KR (1) KR20070034075A (no)
AT (1) ATE443541T1 (no)
AU (1) AU2005256317B2 (no)
BR (1) BRPI0512357A (no)
CA (1) CA2571449C (no)
DE (1) DE602005016803D1 (no)
DK (1) DK1768748T4 (no)
EA (1) EA011814B1 (no)
IL (1) IL180144A0 (no)
MX (1) MXPA06015187A (no)
NO (1) NO20070206L (no)
WO (1) WO2006000224A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2097137T3 (pl) * 2006-11-21 2013-02-28 Mokwalo Spf S A Kompozycje zawierające stront i ich zastosowanie w leczeniu lub zapobieganiu zapaleniu dziąseł, zapaleniu przyzębia, zapaleniu przyzębia będącemu manifestacją chorób układowych i martwiczym chorobom przyzębia
US20080118603A1 (en) * 2006-11-21 2008-05-22 Lada Mark W Nutritional beverage for optimal bone health
ES2573327T3 (es) * 2007-04-23 2016-06-07 Baxter International Inc. Composiciones de fibrina que contienen compuestos de estroncio
KR20100047869A (ko) * 2007-07-19 2010-05-10 디에스엠 아이피 어셋츠 비.브이. 친유성 헬스 성분의 정제화가능한 배합물
US8790714B2 (en) 2007-08-03 2014-07-29 Nucitec, S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis
EP2416756A2 (en) * 2009-04-10 2012-02-15 Mahmut Bilgic Stable pharmaceutical compositions with high bioavailibility
FR2945748A1 (fr) * 2009-05-20 2010-11-26 Debregeas Et Associes Pharma Medicament a base de calcium et de vitamine d.
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
JP5827328B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
WO2012006475A1 (en) * 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590656B1 (en) 2010-07-07 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590655B1 (en) 2010-07-07 2015-06-24 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012006474A2 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
AU2012212385B2 (en) * 2011-02-02 2015-01-15 Ent Technologies Pty Ltd Compositions and methods for the treatment of nasal passages
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2014044756A1 (en) * 2012-09-20 2014-03-27 Mokwalo SA Strontium as anti microbial compound

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
US3699221A (en) * 1965-02-23 1972-10-17 Murray L Schole Dental preparations
US3988434A (en) * 1972-08-07 1976-10-26 Schole Murray L Dental preparation
FR2633619B1 (fr) 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CN1164603C (zh) 2001-09-29 2004-09-01 南京化工大学 1，6－二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844796A1 (fr) 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
PL1622629T3 (pl) * 2003-05-07 2013-12-31 Osteologix As Kompozycja do kontrolowanego uwalniania zawierająca sól strontu
WO2004098618A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.

Also Published As

Publication number Publication date
MXPA06015187A (es) 2007-09-27
CA2571449C (en) 2015-12-08
DK1768748T4 (da) 2019-06-11
IL180144A0 (en) 2007-06-03
KR20070034075A (ko) 2007-03-27
JP2012193208A (ja) 2012-10-11
US8658206B2 (en) 2014-02-25
JP5070046B2 (ja) 2012-11-07
ATE443541T1 (de) 2009-10-15
US20080026037A1 (en) 2008-01-31
HK1102427A1 (en) 2007-11-23
WO2006000224A3 (en) 2006-05-18
JP2008503504A (ja) 2008-02-07
DE602005016803D1 (de) 2009-11-05
EP1768748B1 (en) 2009-09-23
CA2571449A1 (en) 2006-01-05
BRPI0512357A (pt) 2008-03-04
EP1768748A2 (en) 2007-04-04
AU2005256317B2 (en) 2011-09-15
WO2006000224A2 (en) 2006-01-05
AU2005256317A1 (en) 2006-01-05
EA011814B1 (ru) 2009-06-30
EP1768748B2 (en) 2019-03-13
EA200700130A1 (ru) 2007-06-29
DK1768748T3 (da) 2010-02-01

Similar Documents

Publication Publication Date Title
NO20070206L (no) Sammensetninger inneholdende strontium og vitamin D og anvendelser derav
NO2023022I1 (no) cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate
IN2012DN01233A (no)
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MX2009014235A (es) 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
IL193252A0 (en) N-hydroxyacrylamide compounds
MY143795A (en) Tetrahydropyridoindole derivatives
TW200732296A (en) Novel compounds
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MX2009013501A (es) Compuestos piperidinicos y sus usos.
TW200621313A (en) Pharmaceutical compositions
TW200509907A (en) Indol-6-yl sulfonamide derivatives, their preparation and their use in medicaments
TW200738659A (en) Novel compounds
TW200716204A (en) Pharmaceutical composition
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
GB0524814D0 (en) Compounds
TW200800993A (en) Organic compounds
ES2192136A1 (es) Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
TW200745081A (en) Compounds
IL191670A0 (en) Compounds for the inhibition of apoptosis
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
GB0327390D0 (en) Pharmaceutical formulations
SE0203817D0 (sv) New composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application